Healthcare Sector

BMY

Market Tracker

$50.68
+1.07
(+2.16%)
9:40 am
Next Earnings: (est.) 07/27/23 12:00 am
  • BMY (Selected)

    Bristol-Myers Squibb Company

BMY Support / Resistance Levels

Loading Data..
WhaleStream

15m Chart - Support and Resistance levels are based on the large dark pool & equity prints at the plotted levels. Displays strongest levels above and below the spot price.

BMY Most Active Options Strike Prices Whale BUY Activity - 5 day

Loading Data..

Represents the strikes that had the highest premium of whale flow (on the ASK side) over the past 5 trading days.

BMY Most Active Options Strike Prices Whale SALES Activity - 5 day

Loading Data..

Represents the strikes that had the highest premium of whale flow (on the BID side) over the past 5 trading days.

BMY Dark Pool and Public Equity Key Price Levels

Loading Data..

Represents the largest cumulative premium levels above and below the current spot price. The price in the pink bubble represents the spot price.

BMY Open Interest Trend

Loading Data..

Total Open Interest of Calls & Puts across all strikes and expirations over the past 16 trading days.

BMY Largest 1-Day Open Interest Movements

Expires Type Strike OI Change Percent
06/20/2025 PUT $40.00 9,514 +3,575 +60.20%
06/20/2025 PUT $45.00 10,222 +2,769 +37.15%
06/20/2025 CALL $55.00 4,558 +837 +22.49%
06/18/2026 CALL $55.00 1,184 +799 +207.53%
06/20/2025 CALL $50.00 7,919 +367 +4.86%
08/15/2025 PUT $45.00 5,867 +231 +4.10%
05/02/2025 CALL $52.00 200 -24 -10.71%
05/02/2025 PUT $49.00 216 -24 -10.00%
05/02/2025 PUT $47.00 314 -27 -7.92%
05/16/2025 CALL $65.00 13,517 -37 -0.27%
09/19/2025 CALL $52.50 1,768 -40 -2.21%
08/15/2025 PUT $50.00 1,694 -52 -2.98%

Contracts with largest changes in open interest from the previous trading day to the current/most recent.

BMY Major Holders

Name Pct Held Shares Total
Vanguard Total Stock Market Index Fund 3.07% 64.63M 4.03B
Vanguard 500 Index Fund 2.34% 49.15M 3.06B
Fidelity 500 Index Fund 1.11% 23.31M 1.45B
SPDR S&P 500 ETF Trust 1.09% 23.02M 1.43B
iShares Core S&P 500 ETF 0.90% 18.98M 1.18B
Vanguard Index-Value Index Fund 0.87% 18.37M 1.14B
JP Morgan Equity Income Fund 0.82% 17.35M 1.08B
Select Sector SPDR Fund-Health Care 0.82% 17.27M 1.08B
American Mutual Fund Inc 0.78% 16.49M 1.03B
Vanguard Institutional Index Fund-Institutional Index Fund 0.71% 14.9M 927.91M

BMY News

  • FDA Pushes Potential Approval For Cytokinetics' Experimental Heart Drug By Three Months

    05/02 03:37 pm

    Benzinga

    Read more
  • This High-Yield Pharma Stock Looks Like an Incredible Bargain

    04/30 06:45 am

    The Motley Fool

    Read more
  • Analysis of Cancer Immunotherapy Technologies and Global Markets to 2029 - Merck, Roche, Bristol-Myers Squibb Company, Johnson & Johnson Services, and AstraZeneca Dominate

    04/30 04:56 am

    GlobeNewswire Inc.

    Read more
  • 4 Surefire Dividend Stocks to Buy in the Stock Market Sell-Off

    04/26 06:05 pm

    The Motley Fool

    Read more
  • Bristol Myers Delivers Upbeat 2025 Forecast Despite China Tariffs Impact

    04/24 11:55 am

    Benzinga

    Read more
  • Thermo Fisher Beats Q1 Estimates, Lowers Full-Year Forecast As Tariffs And Costs Take A Toll

    04/23 04:49 pm

    Benzinga

    Read more
  • Is High-Yield Pfizer Stock Still a Buy After Scrapping Its Weight-Loss Pill?

    04/15 07:39 am

    The Motley Fool

    Read more
  • These Large-Cap Stocks With China And EU Exposure Got Crushed In The One Of The Most Volatile Trading Week (Apr 7-Apr 11): Are These In Your Portfolio?

    04/13 11:33 am

    Benzinga

    Read more
  • Specialists Set Sights on CLE Pipeline as Unmet Needs Persist and Candidate Pool Expands, According to Spherix Global Insights

    04/10 01:58 pm

    GlobeNewswire Inc.

    Read more
  • Biopharmaceuticals Global Overview Report 2025: Global Market to Reach $698.7 Billion by 2030, Fueled by Specialized Therapies, Such as mAb and Gene Treatments, & a Strong Pipeline

    04/10 05:59 am

    GlobeNewswire Inc.

    Read more
  • Is Vertex Pharmaceuticals Stock a Buy?

    04/08 09:45 am

    The Motley Fool

    Read more
  • Minimal Residual Disease Testing Market Forecast Report, 2025-2030 - Precision Medicine and Early Relapse Detection Drive MRD Testing Demand Worldwide

    04/08 04:48 am

    GlobeNewswire Inc.

    Read more
  • MPYS Protein Stimulants Clinical Trial Pipeline: DelveInsight Highlights Major Advances, Transformative Therapies, and 10+ Leading Players Wheeling the Therapeutics Landscape

    04/07 01:00 pm

    GlobeNewswire Inc.

    Read more
  • Is Bristol Myers Squibb's High-Yielding Dividend Safe?

    04/02 05:40 am

    The Motley Fool

    Read more
  • Tumor-infiltrating Lymphocyte (TIL) Therapies Global Market Report 2025: 75+ Therapies are Under Development and 100+ Clinical Trials are Underway Globally

    04/01 02:44 pm

    GlobeNewswire Inc.

    Read more
  • Beat the S&P 500 With This Cash-Gushing Dividend Stock

    04/01 08:00 am

    The Motley Fool

    Read more
  • Why Pfizer Is My Largest Healthcare Position

    03/27 06:45 am

    The Motley Fool

    Read more
  • Pharmaceutical Firms Say UK Investment Is 'Unlikely' Unless Payment Levy Is Adressed

    03/21 12:31 pm

    Benzinga

    Read more
  • 5 Reasons the Schwab U.S. Dividend Equity ETF Is a Long-Term Buy for 2030 and Beyond

    03/17 07:45 am

    The Motley Fool

    Read more
  • Perspective Therapeutics Announces First Patient Dosed with [212Pb]VMT01 in Combination with Nivolumab in a Phase 1/2a Study of MC1R-Positive Metastatic Melanoma

    03/17 07:00 am

    GlobeNewswire Inc.

    Read more
  • 3 Stocks to Buy Amid Market Correction Triggered by Trump's Trade War

    03/14 07:40 am

    Investing.com

    Read more
  • Bristol Myers Squibb Scoops Up Its Blood Cancer Drug Partner 2seventy Bio In $286 Million Deal

    03/11 10:17 am

    Benzinga

    Read more
  • Bristol Myers Unveils Positive Phase 3 Results for Sotyktu in Psoriatic Arthritis

    03/10 12:54 pm

    Benzinga

    Read more
  • Global Prostate Cancer Market to Reach USD 29.2 Billion by 2035, Driven by Aging Population and Awareness | Future Market Insights, Inc.

    03/09 08:30 pm

    GlobeNewswire Inc.

    Read more
  • Acetylcholine Receptor Antagonists Clinical Trial Pipeline Appears Robust With 30+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight

    03/06 02:00 pm

    GlobeNewswire Inc.

    Read more
  • Cancer Biomarkers Research Report 2024: Global Market Projected to Soar to USD 62.14 Billion by 2034, Driven by Technological Advancements and Increasing Demand for Early Detection

    03/06 05:55 am

    GlobeNewswire Inc.

    Read more
  • Advanced Urothelial Carcinoma Clinical Trial Pipeline Analysis Demonstrates 20+ Key Companies at the Horizon Expected to Transform the Treatment Paradigm, Assesses DelveInsight

    03/03 02:00 pm

    GlobeNewswire Inc.

    Read more
  • International Myeloma Foundation (IMF) Celebrates Myeloma Milestones for 2025 Myeloma Action Month

    03/01 09:45 am

    GlobeNewswire Inc.

    Read more
  • Got $200? 2 Healthcare Stocks to Buy and Hold Forever

    02/26 05:32 am

    The Motley Fool

    Read more
  • TALTZ’s Rapid Market Ascent Reflects its Unparalleled Ability to Transform the Treatment Landscape for Autoimmune Diseases | DelveInsight

    02/24 02:00 pm

    GlobeNewswire Inc.

    Read more
  • Bristol Myers Colorectal Cancer Treatment Goes Under Priority FDA Review

    02/24 01:24 pm

    Benzinga

    Read more
  • Questex’s Fierce Pharma Unveils the Conference Program for the Inaugural Fierce Pharma Engage, Over 100 Speakers Confirmed to Deliver Unparalleled Education

    02/24 11:00 am

    GlobeNewswire Inc.

    Read more
  • CAPLYTA’s Strong Market Adoption Propels Its Rise as a Leading Antipsychotic Therapy | DelveInsight

    02/21 02:00 pm

    GlobeNewswire Inc.

    Read more
  • Hyperlipidemia Drugs Market Size to Promote USD 31.49 Bn by 2034

    02/21 11:00 am

    GlobeNewswire Inc.

    Read more
  • BESREMi Achieves Strong Market Growth Amid Rising Demand for Polycythemia Vera Treatment

    02/20 02:00 pm

    GlobeNewswire Inc.

    Read more
  • Bristol Myers Cancer Drug Opdivo In Combination With Chemo Shows Improved Overall Survival In Certain Patients With Lung Cancer

    02/19 05:14 pm

    Benzinga

    Read more
  • Global Immune Checkpoint Inhibitors Market to Cross USD 100 Billion by 2032 | DelveInsight

    02/18 02:00 pm

    GlobeNewswire Inc.

    Read more
  • Want Decades of Passive Income? Buy This ETF and Hold It Forever.

    02/18 07:15 am

    The Motley Fool

    Read more
  • $536.73 Bn Organ Preservation Solution Market Strategies and Opportunities to 2033: New R&D Center to Revolutionize Organ Preservation Techniques and Enhance Global Healthcare Solutions

    02/12 05:47 am

    GlobeNewswire Inc.

    Read more
  • Bristol Myers Squibb Tops Q4 Estimates

    02/06 10:55 am

    The Motley Fool

    Read more
  • Bristol Myers Squibb Warns Near-Term Impact Due To Generics On 2025 Sales Forecast, Outlines $2 Billion In Additional Cost Cuts

    02/06 10:08 am

    Benzinga

    Read more
  • 2 High-Yield Dividend Stocks to Hold Through 2025 and Beyond

    02/03 09:32 am

    The Motley Fool

    Read more
  • George Medicines appoints Amy Carroll as Senior Vice President of Medical Affairs

    02/03 08:00 am

    GlobeNewswire Inc.

    Read more
  • 3 Cheap Dividend Stocks That Pay More Than Double the S&P 500 Average

    01/29 05:40 am

    The Motley Fool

    Read more
  • Biological Drugs Strategic Research Report 2024-2030, Profiles of 45+ Players Including Abbott Laboratories, Amgen, Baxter, Biogen, BMS, Eli Lilly and Co, GSK, Merck, Novartis, and Pfizer

    01/27 11:49 am

    GlobeNewswire Inc.

    Read more
  • Move Over Mounjaro. Eli Lilly Has Another Blockbuster Opportunity in the Making, and No One Is Talking About It.

    01/25 08:45 am

    The Motley Fool

    Read more
  • 7MM Type 1 Diabetes Market Drug Forecast and Market Analysis 2023-2024 & 2033: Value to Reach $9.91 Billion - Synergistic Rise of Pumps, CGMs, and Ultra-rapid-acting Insulins in T1D Management

    01/17 05:53 am

    GlobeNewswire Inc.

    Read more
  • Like Bristol-Myers Squibb And AbbVie, Johnson & Johnson Seeks To Bolster Neuropsychiatric Portfolio With $15 Billion Deal

    01/13 11:03 am

    Benzinga

    Read more
  • Obesity Treatments, M&A Activity To Take Center Stage During Upcoming JPM Healthcare Conference

    01/09 03:12 pm

    Benzinga

    Read more
  • NUT Midline Carcinoma Treatment Market Research Report 2023-2024 & 2034: Market Forecast by Treatment, Route of Administration, and End-User Across 5 Regions and 17+ Countries

    01/09 11:53 am

    GlobeNewswire Inc.

    Read more
👀

Follow the Whales in real-time.

🎁

Take 50% OFF With Code: